哈药股份：9月26日召开董事会会议

Group 1 - The core viewpoint of the article is that Harbin Pharmaceutical Group Co., Ltd. (哈药股份) has announced the convening of its 2025 first extraordinary general meeting of shareholders during its board meeting held on September 26, 2025 [1] - The company's revenue composition for the year 2024 is detailed as follows: wholesale medical customers account for 36.87%, health products from the pharmaceutical industry account for 16.14%, chemical preparations account for 15.87%, wholesale commercial customers account for 13.99%, and retail in pharmaceutical commerce accounts for 10.46% [1] - As of the report, Harbin Pharmaceutical Group's market capitalization stands at 9.1 billion yuan [1]